DE69729735D1 - Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen - Google Patents

Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen

Info

Publication number
DE69729735D1
DE69729735D1 DE69729735T DE69729735T DE69729735D1 DE 69729735 D1 DE69729735 D1 DE 69729735D1 DE 69729735 T DE69729735 T DE 69729735T DE 69729735 T DE69729735 T DE 69729735T DE 69729735 D1 DE69729735 D1 DE 69729735D1
Authority
DE
Germany
Prior art keywords
benzopyranols
treatment
neurological diseases
neurological
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69729735T
Other languages
English (en)
Other versions
DE69729735T2 (de
Inventor
Andrew A Parsons
Mervyn Thompson
Neil Upton
John Morris Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE69729735D1 publication Critical patent/DE69729735D1/de
Publication of DE69729735T2 publication Critical patent/DE69729735T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DE69729735T 1996-09-18 1997-09-15 Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen Expired - Fee Related DE69729735T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9619492 1996-09-18
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment
PCT/EP1997/005168 WO1998011890A1 (en) 1996-09-18 1997-09-15 Use of benzopyranols to treat neurological disorders

Publications (2)

Publication Number Publication Date
DE69729735D1 true DE69729735D1 (de) 2004-08-05
DE69729735T2 DE69729735T2 (de) 2005-07-14

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729735T Expired - Fee Related DE69729735T2 (de) 1996-09-18 1997-09-15 Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen

Country Status (30)

Country Link
EP (1) EP0939630B1 (de)
JP (1) JP2001500520A (de)
KR (1) KR20000036184A (de)
CN (1) CN1230885A (de)
AP (1) AP9901473A0 (de)
AR (1) AR008838A1 (de)
AT (1) ATE270102T1 (de)
AU (1) AU730465B2 (de)
BG (1) BG103252A (de)
BR (1) BR9712030A (de)
CA (1) CA2266681A1 (de)
DE (1) DE69729735T2 (de)
DZ (1) DZ2311A1 (de)
EA (1) EA199900306A1 (de)
ES (1) ES2223075T3 (de)
GB (1) GB9619492D0 (de)
HU (1) HUP9904638A3 (de)
ID (2) ID23175A (de)
IL (1) IL128786A0 (de)
MA (1) MA24321A1 (de)
NO (1) NO991292D0 (de)
NZ (1) NZ334271A (de)
OA (1) OA10998A (de)
PE (1) PE109898A1 (de)
PL (1) PL332313A1 (de)
SK (1) SK35199A3 (de)
TR (1) TR199900527T2 (de)
UY (1) UY24717A1 (de)
WO (1) WO1998011890A1 (de)
ZA (1) ZA978359B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
WO2009147441A2 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
MX2010013313A (es) * 2008-06-05 2011-05-30 Minster Res Ltd Tratamientos novedosos.
CA2774715C (en) 2009-07-27 2018-04-03 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
AU2010325755A1 (en) * 2009-12-03 2012-06-21 Proximagen Ltd Treatment of infectious diseases
AU2010325756A1 (en) * 2009-12-03 2012-06-21 Proximagen Ltd Treatment of allodynia and hyperalgesia
CA2802288C (en) 2010-07-02 2018-08-21 Gilead Sciences, Inc. Triazolopyridinone compounds as ion channel modulators
KR20140033377A (ko) 2011-05-10 2014-03-18 길리애드 사이언시즈, 인코포레이티드 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
NO3175985T3 (de) 2011-07-01 2018-04-28
TWI549944B (zh) 2011-07-01 2016-09-21 吉李德科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
DE69524871T2 (de) * 1994-06-10 2002-08-22 Smithkline Beecham Plc Benzopyrans und deren verwendung als therapeutische mittel

Also Published As

Publication number Publication date
ES2223075T3 (es) 2005-02-16
HUP9904638A2 (hu) 2001-05-28
EP0939630B1 (de) 2004-06-30
NO991292L (no) 1999-03-17
IL128786A0 (en) 2000-01-31
AU4704797A (en) 1998-04-14
WO1998011890A1 (en) 1998-03-26
JP2001500520A (ja) 2001-01-16
DZ2311A1 (fr) 2002-12-28
NZ334271A (en) 2001-03-30
ATE270102T1 (de) 2004-07-15
GB9619492D0 (en) 1996-10-30
BR9712030A (pt) 1999-08-24
AP9901473A0 (en) 1999-03-31
EP0939630A1 (de) 1999-09-08
BG103252A (en) 1999-09-30
ZA978359B (en) 1999-03-17
AU730465B2 (en) 2001-03-08
OA10998A (en) 2003-03-04
ID19542A (id) 1998-07-23
EA199900306A1 (ru) 1999-08-26
DE69729735T2 (de) 2005-07-14
SK35199A3 (en) 2000-07-11
NO991292D0 (no) 1999-03-17
TR199900527T2 (xx) 1999-06-21
CA2266681A1 (en) 1998-03-26
CN1230885A (zh) 1999-10-06
HUP9904638A3 (en) 2001-08-28
AR008838A1 (es) 2000-02-23
UY24717A1 (es) 2001-08-27
PE109898A1 (es) 1999-03-21
MA24321A1 (fr) 1998-04-01
PL332313A1 (en) 1999-08-30
KR20000036184A (ko) 2000-06-26
ID23175A (id) 2000-03-23

Similar Documents

Publication Publication Date Title
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69822638D1 (de) Heterocyclische vinylether zur behandlung neurologischer krankheiten
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
DE69734513D1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE69509544T2 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69526935D1 (de) Verwendung von mycobacterium zur tumorbehandlung
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69924284D1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE69701458D1 (de) Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee